Yalin Tu

机构：Jinan University, Chinese University of Hong Kong, University of Jinan, Ministry of Education · ORCID：0000-0002-6705-683X

发表论文 64 篇 · 总被引 1040 次 · h-index 15

代表论文

• A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma (2021 · Science Translational Medicine · 被引 173)
• Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma (2023 · Gut · 被引 115)
• Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma (2021 · Journal of Medicinal Chemistry · 被引 95)
• Pharmacological activation of STAT1-GSDME pyroptotic circuitry reinforces epigenetic immunotherapy for hepatocellular carcinoma (2024 · Gut · 被引 42)
• Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis (2021 · Cancer Letters · 被引 42)
• The mitotic regulator RCC2 promotes glucose metabolism through BACH1-dependent transcriptional upregulation of hexokinase II in glioma (2022 · Cancer Letters · 被引 24)